Neureka Health
Glossary
Glossary·Concept

Glymphatic system

Also known as: glymphatic clearance, perivascular clearance, brain waste clearance

A brain-wide network of fluid channels, driven largely during sleep, that clears metabolic waste — including proteins linked to neurodegeneration — from brain tissue.

The glymphatic system (a portmanteau of glial and lymphatic) is a brain-wide fluid transport network first described systematically by Maiken Nedergaard's group in 2012–2013. It provides the brain — an organ without conventional lymph vessels — with a dedicated mechanism for clearing metabolic waste.

How it works

The system exploits the perivascular spaces that surround every blood vessel in the brain. These spaces act as channels:

  1. CSF enters the brain along the outside of arteries, driven partly by arterial pulsation and partly by pressure gradients
  2. Fluid moves through brain tissue via aquaporin-4 (AQP4) water channels on astrocyte endfeet that ensheath the vessels
  3. The fluid flushes the interstitial space, picking up metabolic by-products
  4. Waste-laden fluid drains out along veins, eventually reaching cervical lymph nodes

Sleep and glymphatic function

One of the most striking findings in this field is that glymphatic clearance is dramatically more efficient during sleep — particularly during slow-wave (deep) sleep. During sleep:

  • The brain's interstitial space expands by ~60%, reducing resistance to fluid flow
  • Clearance of solutes, including amyloid-β, increases by up to tenfold compared to waking

This provides a compelling biological mechanism linking poor sleep to accelerated brain ageing. Chronic sleep disruption reduces glymphatic clearance efficiency, allowing waste products — including amyloid-β and tau — to accumulate at higher levels between clearance cycles.

Relevance to neurodegeneration

Amyloid-β and tau — the two proteins central to Alzheimer's disease pathology — are among the substrates that the glymphatic system clears. Impaired glymphatic function has been proposed as an upstream contributor to their accumulation, though the field is still establishing causality in humans (much of the foundational work is in rodents).

Age itself reduces glymphatic efficiency: AQP4 expression and polarisation decline with age, and arterial stiffness (which reduces the pulsatile driving force) increases.

Clinical and research relevance

Glymphatic function cannot yet be measured routinely in humans — there is no standard clinical imaging protocol. Research approaches include:

  • DTI-ALPS (diffusion tensor image analysis along the perivascular space) — an indirect MRI marker
  • Gadolinium-based tracer studies — used in research contexts to track CSF flow
  • Sleep EEG slow-wave power — as a proxy for the sleep states that drive clearance

Read more